ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,272.47
0.42%
Dow Jones
39,242.84
0.24%
Gold vs US Dollar
2,329.95
0.51%
Brent Oil
84.655
0.76%
Bitcoin
61,249.94
-3.02%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Acorda Therapeutics Inc (ACOR) Share Price

ACOR Acorda Therapeutics Inc

0.661
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Acorda Therapeutics Inc NASDAQ:ACOR NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.661 0.565 0.5878 0.00 0.00   00:00:00   
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ACOR News
15/04/202422:03BWAcorda Therapeutics Announces Delisting from Nasdaq
03/04/202422:30BWAcorda Therapeutics Announces Nasdaq Delisting Notification
01/04/202423:35BWAcorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
01/04/202421:01BWAcorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
25/03/202420:01BWAcorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
11/01/202413:33EDGAR2Form 8-K - Current report
11/01/202413:01BWAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
06/09/202007:48PBBACCOR: The Best Hotel Group in the World83
Data Downloads for ACOR

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Acorda Therapeutics Inc Articles